Organism name | Allium tuberosum Rottl.ex Spreng. |
---|---|
Genus | Allium |
Family | Alliaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Allium |
---|---|
Linked NCBI taxonomy ID | 4678 |
Linked level | genus |
Family in NCBI taxonomy | Amaryllidaceae |
---|---|
ID | 4668 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Liliopsida |
---|---|
ID | 4447 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001165
![]() |
Mannitol
/ D-Mannitol |
CHEMBL16105
CHEMBL689 CHEMBL1682 CHEMBL1735282 CHEMBL1773904 |
D008353
|
101 / 49 / 42 | 10 / 42 | No. 630 |
![]() |
|
C00007444
![]() |
Adenosine
|
CHEMBL477
CHEMBL11909 CHEMBL20247 CHEMBL1090 CHEMBL91573 CHEMBL145188 CHEMBL1236872 CHEMBL1413677 CHEMBL2051971 |
D000241
|
61 / 89 / 68 | 33 / 35 | No. 1060 |
![]() |
|
C00019692
![]() |
Inosine
|
CHEMBL9850
CHEMBL1556 CHEMBL1213651 CHEMBL2092757 |
D007288
|
13 / 14 / 5 | 2 / 2 | No. 1761 |
![]() |
|
C00001397
![]() |
L-Tyrosine
|
CHEMBL925
CHEMBL108615 CHEMBL1076637 |
17 / 9 / 14 | No. 3303 |
![]() |
|||
C00037771
![]() |
S-Allylcysteine
|
CHEMBL1592541
CHEMBL2048654 |
C065299
|
5 / 5 / 3 | 4 / 6 | No. 6469 |
![]() |
|
C00007468
![]() |
Allantoin
|
CHEMBL593429
CHEMBL1230080 |
D000481
|
12 / 12 / 14 | No. 8950 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001165 C00007444 C00007468 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001165 C00007444 C00007468 | 0 / 1 |
O75496 | Geminin | Unclassified protein | C00001165 C00007444 C00019692 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001165 C00007444 C00007468 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001165 C00007444 C00007468 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001165 C00007444 C00007468 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001397 C00007444 | 2 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001165 C00007444 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001165 C00019692 | 0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00007444 C00019692 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00001397 C00007444 | 2 / 5 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001165 C00007444 | 2 / 2 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001165 C00007444 | 1 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001165 C00007444 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00007444 C00019692 | 4 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00001165 C00007444 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001165 C00007444 | 5 / 9 |
P23526 | Adenosylhomocysteinase | Enzyme | C00007444 C00019692 | 1 / 1 |
P39748 | Flap endonuclease 1 | Enzyme | C00001165 C00007444 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00019692 C00037771 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001165 C00007444 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001165 C00007444 | 1 / 8 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001397 C00007444 | 1 / 2 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001165 C00007444 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001165 C00007444 | 0 / 1 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001165 C00019692 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001165 C00007444 | 11 / 10 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001165 C00001397 | 1 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00007444 C00007468 | 3 / 2 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001165 | 0 / 0 |
P00813 | Adenosine deaminase | Hydrolase | C00007444 | 1 / 1 |
P12268 | Inosine-5'-monophosphate dehydrogenase 2 | Oxidoreductase | C00007444 | 0 / 0 |
Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | Unclassified protein | C00007444 | 1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00019692 | 3 / 1 |
P29275 | Adenosine receptor A2b | Adenosine receptor | C00007444 | 0 / 0 |
O14924 | Regulator of G-protein signaling 12 | Unclassified protein | C00007468 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001165 | 2 / 2 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001165 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001165 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001165 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001165 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001165 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00007444 | 0 / 0 |
P04183 | Thymidine kinase, cytosolic | Enzyme | C00007444 | 0 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00001165 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001165 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001165 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001165 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001165 | 0 / 0 |
Q9HBX9 | Relaxin receptor 1 | Relaxin receptor | C00007444 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00019692 | 1 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00001165 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00007468 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001165 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001165 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001165 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001165 | 0 / 0 |
P47901 | Vasopressin V1b receptor | Vasopressin and oxytocin receptor | C00007444 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001165 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001165 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001397 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001165 | 0 / 0 |
P05164 | Myeloperoxidase | Enzyme | C00001397 | 1 / 2 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001165 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001165 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001165 | 1 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001397 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00001397 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00001397 | 1 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001165 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00007444 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001397 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001165 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00007444 | 1 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00019692 | 2 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001397 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001165 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001165 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001165 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001165 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001165 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001165 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001165 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001165 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001165 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001165 | 1 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001397 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001165 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001165 | 0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00007444 | 0 / 1 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001165 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00001165 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001165 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00007444 | 7 / 3 |
P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | C00007444 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001165 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001165 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00007468 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001165 | 0 / 1 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00007444 | 5 / 4 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001165 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001165 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001165 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001165 | 2 / 0 |
P41240 | Tyrosine-protein kinase CSK | Csk | C00001397 | 0 / 0 |
P09619 | Platelet-derived growth factor receptor beta | Pdgfr | C00007444 | 5 / 1 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001165 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001165 | 0 / 0 |
P55263 | Adenosine kinase | Enzyme | C00007444 | 1 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001165 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001165 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001165 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001165 | 1 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001165 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001165 | 2 / 1 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001165 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00001397 | 0 / 1 |
Q8WXD0 | Relaxin receptor 2 | Relaxin receptor | C00007444 | 1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00007444 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001165 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001165 | 1 / 1 |
P08246 | Neutrophil elastase | S1A | C00001165 | 2 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00001165 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001165 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001165 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001165 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001165 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001165 | 0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00007468 | 4 / 2 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001165 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00007444 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00007444 | 0 / 0 |
P00491 | Purine nucleoside phosphorylase | Enzyme | C00019692 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001165 | 0 / 3 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001165 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001165 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00007444 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00007444 | 4 / 3 |
Q6DHV7 | Adenosine deaminase-like protein | Enzyme | C00007444 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001165 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001165 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
P20839 | Inosine-5'-monophosphate dehydrogenase 1 | Oxidoreductase | C00007444 | 2 / 2 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001165 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001165 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00001397 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001165 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001165 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001397 | 1 / 1 |
Q9GZV3 | High affinity choline transporter 1 | Choline Na-symporter | C00007444 | 1 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00037771 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00007444 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00019692 | 1 / 1 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00019692 | 0 / 0 |
P10323 | Acrosin | S1A | C00001165 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00007468 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00007468 | 1 / 4 |
P11362 | Fibroblast growth factor receptor 1 | Fgfr | C00007444 | 4 / 5 |
P22455 | Fibroblast growth factor receptor 4 | Fgfr | C00007444 | 0 / 0 |
P22607 | Fibroblast growth factor receptor 3 | Fgfr | C00007444 | 14 / 6 |
P21802 | Fibroblast growth factor receptor 2 | TK tyrosine-protein kinase TLK subfamily | C00007444 | 9 / 3 |
P07205 | Phosphoglycerate kinase 2 | Enzyme | C00007444 | 0 / 0 |
P00558 | Phosphoglycerate kinase 1 | Enzyme | C00007444 | 1 / 1 |
Q9UBF8 | Phosphatidylinositol 4-kinase beta | Enzyme | C00007444 | 0 / 0 |
Q8TCG2 | Phosphatidylinositol 4-kinase type 2-beta | Enzyme | C00007444 | 0 / 0 |
Q9BTU6 | Phosphatidylinositol 4-kinase type 2-alpha | Enzyme | C00007444 | 0 / 0 |
P42356 | Phosphatidylinositol 4-kinase alpha | Enzyme | C00007444 | 0 / 0 |
P37088 | Amiloride-sensitive sodium channel subunit alpha | NA | C00037771 | 2 / 2 |
P51168 | Amiloride-sensitive sodium channel subunit beta | Unclassified protein | C00037771 | 3 / 3 |
P51170 | Amiloride-sensitive sodium channel subunit gamma | Unclassified protein | C00037771 | 2 / 3 |
Q05BR4 | SLC16A10 protein | Unclassified protein | C00001397 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001165 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001165
C00007444
C00037771
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001165
C00007444
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00007444
C00019692
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00001165
C00007444
|
100 | ADA | adenosine deaminase (EC:3.5.4.4) |
C00007444
C00019692
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00037771
|
135 | ADORA2A, A2aR, ADORA2, RDC8 | adenosine A2a receptor |
C00007444
|
140 | ADORA3, A3AR, AD026, bA552M11.5 | adenosine A3 receptor |
C00007444
|
248 | ALPI, IAP | alkaline phosphatase, intestinal (EC:3.1.3.1) |
C00007444
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00007444
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00007444
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00007444
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00007444
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00007444
|
3728 | JUP, ARVD12, CTNNG, DP3, DPIII, PDGB, PKGB | junction plakoglobin |
C00037771
|
929 | CD14 | CD14 molecule |
C00007444
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00007444
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00007444
|
56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein |
C00007444
|
1803 | DPP4, ADABP, ADCP2, CD26, DPPIV, TP103 | dipeptidyl-peptidase 4 (EC:3.4.14.5) |
C00007444
|
8772 | FADD, MORT1 | Fas (TNFRSF6)-associated via death domain |
C00007444
|
134 | ADORA1, RDC7 | adenosine A1 receptor |
C00007444
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00007444
|
23643 | LY96, ESOP-1, MD-2, MD2, ly-96 | lymphocyte antigen 96 |
C00007444
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00037771
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00007444
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00007444
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00007444
|
9154 | SLC28A1, CNT1, HCNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 1 |
C00007444
|
9153 | SLC28A2, CNT2, HCNT2, HsT17153, SPNT1 | solute carrier family 28 (concentrative nucleoside transporter), member 2 |
C00007444
|
2030 | SLC29A1, ENT1 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
C00007444
|
3177 | SLC29A2, DER12, ENT2, HNP36 | solute carrier family 29 (equilibrative nucleoside transporter), member 2 |
C00007444
|
55315 | SLC29A3, ENT3, HCLAP, HJCD, PHID | solute carrier family 29 (equilibrative nucleoside transporter), member 3 |
C00007444
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00007444
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00007444
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00007444
|
3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00001165
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001165
|
4878 | NPPA, ANF, ANP, ATFB6, CDD-ANF, PND | natriuretic peptide A |
C00001165
|
27250 | PDCD4, H731 | programmed cell death 4 (neoplastic transformation inhibitor) |
C00001165
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00001165
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00001165
|
7163 | TPD52, D52, N8L, PC-1, PrLZ, hD52 | tumor protein D52 |
C00001165
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#100800 | Achondroplasia; ach |
P22607
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#207410 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis; abs2 |
P21802
|
#101200 | Apert syndrome |
P21802
|
#615007 | Basal ganglia calcification, idiopathic, 4; ibgc4 |
P09619
|
#123790 | Beare-stevenson cutis gyrata syndrome; bstvs |
P21802
|
#614592 | Bent bone dysplasia syndrome; bbds |
P21802
|
#109800 | Bladder cancer |
P22607
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#211400 | Bronchiectasis with or without elevated sweat chloride 1; besc1 |
P51168
|
#613021 | Bronchiectasis with or without elevated sweat chloride 2; besc2 |
P37088
|
#613071 | Bronchiectasis with or without elevated sweat chloride 3; besc3 |
P51170
|
#300615 | Brunner syndrome |
P21397
|
#610474 | Camptodactyly, tall stature, and hearing loss syndrome |
P22607
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#603956 | Cervical cancer |
P22607
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#123500 | Crouzon syndrome |
P21802
|
#612247 | Crouzon syndrome with acanthosis nigricans; can |
P22607
|
#219050 | Cryptorchidism, unilateral or bilateral |
Q8WXD0
|
#162800 | Cyclic neutropenia |
P08246
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#246200 | Donohue syndrome |
P06213
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#614300 | Hypermethioninemia due to adenosine kinase deficiency |
P55263
|
#613752 | Hypermethioninemia with s-adenosylhomocysteine hydrolase deficiency |
P23526
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#146000 | Hypochondroplasia; hch |
P22607
|
#147950 | Hypogonadotropic hypogonadism 2 with or without anosmia; hh2 |
P11362
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#123150 | Jackson-weiss syndrome; jws |
P21802
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
P09619
|
#182000 | Keratosis, seborrheic |
P22607
|
#149730 | Lacrimoauriculodentodigital syndrome; ladd |
P21802
P22607 |
#613837 | Leber congenital amaurosis 11; lca11 |
P20839
|
#601626 | Leukemia, acute myeloid; aml |
P09619
|
#177200 | Liddle syndrome |
P51168
P51170 |
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#602849 | Muenke syndrome; mnkes |
P22607
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#254500 | Myeloma, multiple |
P22607
|
#254600 | Myeloperoxidase deficiency; mpod |
P05164
|
#131440 | Myeloproliferative disorder, chronic, with eosinophilia |
P09619
|
#159900 | Myoclonic dystonia |
P14416
|
#228550 | Myofibromatosis, infantile, 1; imf1 |
P09619
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#158580 | Neuronopathy, distal hereditary motor, type viia; hmn7a |
Q9GZV3
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#162900 | Nevus, epidermal |
P22607
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#166250 | Osteoglophonic dysplasia; ogd |
P11362
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#101600 | Pfeiffer syndrome |
P11362
P21802 |
#300653 | Phosphoglycerate kinase 1 deficiency |
P00558
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#604559 | Progressive familial heart block, type ib; pfhb1b |
Q8TD43
|
#264350 | Pseudohypoaldosteronism, type i, autosomal recessive; pha1b |
P37088
P51168 |
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#613179 | Purine nucleoside phosphorylase deficiency |
P00491
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#180105 | Retinitis pigmentosa 10; rp10 |
P20839
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#609579 | Scaphocephaly, maxillary retrusion, and mental retardation |
P21802
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#102700 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency |
P00813
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#273300 | Testicular germ cell tumor; tgct |
P22607
|
#187600 | Thanatophoric dysplasia, type i; td1 |
P22607
|
#187601 | Thanatophoric dysplasia, type ii; td2 |
P22607
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#190440 | Trigonocephaly 1; trigno1 |
P11362
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00093 | Combined immunodeficiencies (CIDs) |
P00491
(related)
P06239 (related) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P21802 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P22607 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P09619 (related) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00664 | Anemia due to disorders of glycolytic enzymes |
P00558
(related)
|
H00092 | T-B-Severe combined immunodeficiencies (SCIDs) |
P00813
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00101 | Other phagocyte defects |
P05164
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P05164
(marker)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00255 | Hypogonadotropic hypogonadism |
P11362
(related)
|
H00443 | Osteoglophonic dysplasia (OD) |
P11362
(related)
|
H00458 | Craniosynostosis |
P11362
(related)
P21802 (related) P22607 (related) |
H00516 | Isolated orofacial clefts |
P11362
(related)
|
H01207 | Trigonocephaly |
P11362
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P20839
(related)
P22748 (related) |
H00837 | Leber congenital amaurosis (LCR) |
P20839
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00642 | Lacrimo-auriculo-dento-digital syndrome (LADD) |
P21802
(related)
P22607 (related) |
H00010 | Multiple myeloma |
P22607
(related)
|
H00505 | FGFR3-related short limb skeletal dysplasias |
P22607
(related)
|
H00997 | CATSHL syndrome |
P22607
(related)
|
H00184 | Hypermethioninemia |
P23526
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00032 | Thyroid cancer |
P27487
(marker)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00243 | Hyperkalemic distal renal tubular acidosis (RTA type 4) |
P37088
(related)
P51168 (related) P51170 (related) |
H00892 | Bronchiectasis with or without elevated sweat chloride |
P37088
(related)
P51168 (related) P51170 (related) |
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00242 | Liddle syndrome |
P51168
(related)
P51170 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H01263 | Progressive cardiac conduction defect (PCCD) |
Q8TD43
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
Q8WXD0
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006331 | Heart Diseases |
C00037771
C00001165 |
D014693 | Ventricular Fibrillation |
C00007444
C00001165 |
D009422 | Nervous System Diseases |
C00007444
C00001165 |
D009336 | Necrosis |
C00007444
C00001165 |
D017202 | Myocardial Ischemia |
C00007444
C00001165 |
D007022 | Hypotension |
C00007444
C00001165 |
D009202 | Cardiomyopathies |
C00007444
C00019692 |
D002545 | Brain Ischemia |
C00007444
C00001165 |
D034381 | Hearing Loss |
C00001165
|
D054537 | Atrioventricular Block |
C00007444
|
D001321 | Autistic Disorder |
C00007444
|
D001919 | Bradycardia |
C00007444
|
D001249 | Asthma |
C00007444
|
D001986 | Bronchial Spasm |
C00007444
|
D001145 | Arrhythmias, Cardiac |
C00007444
|
D002389 | Catatonia |
C00007444
|
D002637 | Chest Pain |
C00007444
|
D004244 | Dizziness |
C00007444
|
D004827 | Epilepsy |
C00007444
|
D004830 | Epilepsy, Tonic-Clonic |
C00007444
|
D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00007444
|
D006333 | Heart Failure |
C00007444
|
D006930 | Hyperalgesia |
C00007444
|
D006940 | Hyperemia |
C00007444
|
D006973 | Hypertension |
C00007444
|
D006977 | Hypertension, Renal |
C00007444
|
D001745 | Urinary Bladder Diseases |
C00037771
|
D007174 | Impulse Control Disorders |
C00007444
|
D008106 | Liver Cirrhosis, Experimental |
C00007444
|
D011658 | Pulmonary Fibrosis |
C00037771
|
D011471 | Prostatic Neoplasms |
C00037771
|
D009410 | Nerve Degeneration |
C00007444
|
D009203 | Myocardial Infarction |
C00037771
|
D010146 | Pain |
C00007444
|
D012640 | Seizures |
C00007444
|
D054138 | Sinus Arrest, Cardiac |
C00007444
|
D013610 | Tachycardia |
C00007444
|
D013617 | Tachycardia, Supraventricular |
C00007444
|
D017180 | Tachycardia, Ventricular |
C00007444
|
D014202 | Tremor |
C00007444
|
D003921 | Diabetes Mellitus, Experimental |
C00037771
|
D007970 | Leukopenia |
C00019692
|
D058186 | Acute Kidney Injury |
C00001165
|
D055371 | Acute Lung Injury |
C00001165
|
D053099 | Azotemia |
C00001165
|
D001929 | Brain Edema |
C00001165
|
D002543 | Cerebral Hemorrhage |
C00001165
|
D003128 | COMA |
C00001165
|
D003161 | Compartment Syndromes |
C00001165
|
D006259 | Craniocerebral Trauma |
C00001165
|
D003875 | Drug Eruptions |
C00001165
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001165
|
D004487 | Edema |
C00001165
|
D004660 | Encephalitis |
C00001165
|
D005901 | Glaucoma |
C00001165
|
D015812 | Glaucoma, Angle-Closure |
C00001165
|
D005910 | Glioma |
C00001165
|
D001282 | Atrial Flutter |
C00007444
|
D006505 | Hepatitis |
C00001165
|
D006955 | Hypernatremia |
C00001165
|
D007008 | Hypokalemia |
C00001165
|
D007010 | Hyponatremia |
C00001165
|
D007177 | Inappropriate ADH Syndrome |
C00001165
|
D019586 | Intracranial Hypertension |
C00001165
|
D002546 | Ischemic Attack, Transient |
C00001165
|
D007674 | Kidney Diseases |
C00001165
|
D008579 | Meningioma |
C00001165
|
D009401 | Nephrosis |
C00001165
|
D009846 | Oliguria |
C00001165
|
D054038 | Posterior Leukoencephalopathy Syndrome |
C00001165
|
D011654 | Pulmonary Edema |
C00001165
|
D011655 | Pulmonary Embolism |
C00001165
|
D051437 | Renal Insufficiency |
C00001165
|
D015427 | Reperfusion Injury |
C00001165
|
D012769 | Shock |
C00001165
|
D020521 | Stroke |
C00001165
|
D014581 | Urticaria |
C00001165
|